Literature DB >> 21601374

Sequencing of local therapy affects the pattern of treatment failure and survival in children with atypical teratoid rhabdoid tumors of the central nervous system.

Atmaram S Pai Panandiker1, Thomas E Merchant, Chris Beltran, Shengjie Wu, Shelly Sharma, Frederick A Boop, Jesse J Jenkins, Kathleen J Helton, Karen D Wright, Alberto Broniscer, Larry E Kun, Amar Gajjar.   

Abstract

PURPOSE: To assess the pattern of treatment failure associated with current therapeutic paradigms for childhood atypical teratoid rhabdoid tumors (AT/RT). METHODS AND MATERIALS: Pediatric patients with AT/RT of the central nervous system treated at our institution between 1987 and 2007 were retrospectively evaluated. Overall survival (OS), progression-free survival, and cumulative incidence of local failure were correlated with age, sex, tumor location, extent of disease, and extent of surgical resection. Radiotherapy (RT) sequencing, chemotherapy, dose, timing, and volume administered after resection were also evaluated.
RESULTS: Thirty-one patients at a median age of 2.3 years at diagnosis (range, 0.45-16.87 years) were enrolled into protocols that included risk- and age-stratified RT. Craniospinal irradiation with focal tumor bed boost (median dose, 54 Gy) was administered to 18 patients. Gross total resection was achieved in 16. Ten patients presented with metastases at diagnosis. RT was delayed more than 3 months in 20 patients and between 1 and 3 months in 4; 7 patients received immediate postoperative irradiation preceding high-dose alkylator-based chemotherapy. At a median follow-up of 48 months, the cumulative incidence of local treatment failure was 37.5% ± 9%; progression-free survival was 33.2% ± 10%; and OS was 53.5% ± 10%. Children receiving delayed RT (≥1 month postoperatively) were more likely to experience local failure (hazard ratio [HR] 1.23, p = 0.007); the development of distant metastases before RT increased the risk of progression (HR 3.49, p = 0.006); and any evidence of disease progressionbefore RT decreased OS (HR 20.78, p = 0.004). Disease progression occurred in 52% (11/21) of children with initially localized tumors who underwent gross total resection, and the progression rate increased proportionally with increasing delay from surgery to RT.
CONCLUSIONS: Delayed RT is associated with a higher rate of local and metastatic disease progression in children with AT/RT. Current treatment regimens for pediatric patients with AT/RT are distinctly age stratified; novel protocols investigating RT volumes and sequencing are needed. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21601374      PMCID: PMC3530399          DOI: 10.1016/j.ijrobp.2011.02.059

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  22 in total

1.  Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma.

Authors:  Raymond K Mulhern; Shawna L Palmer; Thomas E Merchant; Dana Wallace; Mehmet Kocak; Pim Brouwers; Kevin Krull; Murali Chintagumpala; Robyn Stargatt; David M Ashley; Vida L Tyc; Larry Kun; James Boyett; Amar Gajjar
Journal:  J Clin Oncol       Date:  2005-08-20       Impact factor: 44.544

2.  Impact of radiotherapy for pediatric CNS atypical teratoid/rhabdoid tumor (single institute experience).

Authors:  Yi-Wei Chen; Tai-Tong Wong; Donald Ming-Tak Ho; Pin-I Huang; Kai-Ping Chang; Cheng-Ying Shiau; Sang-Hue Yen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-01-06       Impact factor: 7.038

3.  Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors.

Authors:  J A Biegel; J Y Zhou; L B Rorke; C Stenstrom; L M Wainwright; B Fogelgren
Journal:  Cancer Res       Date:  1999-01-01       Impact factor: 12.701

4.  Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.

Authors:  Amar Gajjar; Murali Chintagumpala; David Ashley; Stewart Kellie; Larry E Kun; Thomas E Merchant; Shaio Woo; Greg Wheeler; Valerie Ahern; Matthew J Krasin; Maryam Fouladi; Alberto Broniscer; Robert Krance; Gregory A Hale; Clinton F Stewart; Robert Dauser; Robert A Sanford; Christine Fuller; Ching Lau; James M Boyett; Dana Wallace; Richard J Gilbertson
Journal:  Lancet Oncol       Date:  2006-10       Impact factor: 41.316

5.  Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy.

Authors:  Tanya M Tekautz; Christine E Fuller; Susan Blaney; Maryam Fouladi; Alberto Broniscer; Thomas E Merchant; Matthew Krasin; James Dalton; Gregory Hale; Larry E Kun; Dana Wallace; Richard J Gilbertson; Amar Gajjar
Journal:  J Clin Oncol       Date:  2005-03-01       Impact factor: 44.544

6.  Neuroradiological findings in atypical teratoid/rhabdoid tumor of the central nervous system.

Authors:  Y C Cheng; J F Lirng; F C Chang; W Y Guo; M M H Teng; C Y Chang; T T Wong; D M T Ho
Journal:  Acta Radiol       Date:  2005-02       Impact factor: 1.990

7.  Intellectual and functional outcome of children 3 years old or younger who have CNS malignancies.

Authors:  Maryam Fouladi; Elizabeth Gilger; Mehmet Kocak; Dana Wallace; Gray Buchanan; Cara Reeves; Nicole Robbins; Thomas Merchant; Larry E Kun; Raja Khan; Amar Gajjar; Raymond Mulhern
Journal:  J Clin Oncol       Date:  2005-10-01       Impact factor: 44.544

8.  Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function.

Authors:  Thomas E Merchant; Chia-Ho Hua; Hemant Shukla; Xiaofei Ying; Simeon Nill; Uwe Oelfke
Journal:  Pediatr Blood Cancer       Date:  2008-07       Impact factor: 3.167

9.  Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor.

Authors:  Susan N Chi; Mary Ann Zimmerman; Xiaopan Yao; Kenneth J Cohen; Peter Burger; Jaclyn A Biegel; Lucy B Rorke-Adams; Michael J Fisher; Anna Janss; Claire Mazewski; Stewart Goldman; Peter E Manley; Daniel C Bowers; Anne Bendel; Joshua Rubin; Christopher D Turner; Karen J Marcus; Liliana Goumnerova; Nicole J Ullrich; Mark W Kieran
Journal:  J Clin Oncol       Date:  2008-12-08       Impact factor: 44.544

10.  White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor.

Authors:  Maryam Fouladi; Murali Chintagumpala; Fred H Laningham; David Ashley; Stewart J Kellie; James W Langston; Charles W McCluggage; Shaio Woo; Mehmet Kocak; Kevin Krull; Larry E Kun; Raymond K Mulhern; Amar Gajjar
Journal:  J Clin Oncol       Date:  2004-11-15       Impact factor: 44.544

View more
  22 in total

1.  Tumor control and QoL outcomes of very young children with atypical teratoid/rhabdoid tumor treated with focal only chemo-radiation therapy using pencil beam scanning proton therapy.

Authors:  Damien C Weber; Carmen Ares; Robert Malyapa; Francesca Albertini; Gabriele Calaminus; Ulrike Kliebsch; Lorentzos Mikroutsikos; Petra Morach; Alessandra Bolsi; Tony Lomax; Ralf Schneider
Journal:  J Neurooncol       Date:  2014-11-02       Impact factor: 4.130

2.  Atypical teratoid rhabdoid tumor: long-term survival after chemoradiotherapy.

Authors:  Vivek Verma; Catrina P Johnson; Nathan R Bennion; Abhijeet R Bhirud; Sicong Li; Rodney D McComb; Chi Lin
Journal:  Childs Nerv Syst       Date:  2015-05-05       Impact factor: 1.475

3.  Overall Survival of Primary Intracranial Atypical Teratoid Rhabdoid Tumor Following Multimodal Treatment: A Pooled Analysis of Individual Patient Data.

Authors:  Xiu-Jian Ma; Da Li; Liang Wang; Shu-Yu Hao; Li-Wei Zhang; Jun-Ting Zhang; Zhen Wu
Journal:  Neurosurg Rev       Date:  2018-12-08       Impact factor: 3.042

Review 4.  Atypical teratoid/rhabdoid tumors-current concepts, advances in biology, and potential future therapies.

Authors:  Michael C Frühwald; Jaclyn A Biegel; Franck Bourdeaut; Charles W M Roberts; Susan N Chi
Journal:  Neuro Oncol       Date:  2016-01-10       Impact factor: 12.300

5.  The descriptive epidemiology of atypical teratoid/rhabdoid tumors in the United States, 2001-2010.

Authors:  Quinn T Ostrom; Yanwen Chen; Peter M de Blank; Annie Ondracek; Paul Farah; Haley Gittleman; Yingli Wolinsky; Carol Kruchko; Mark L Cohen; Daniel J Brat; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2014-05-20       Impact factor: 12.300

6.  Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children.

Authors:  Cynthia Wetmore; James Boyett; Shaoyu Li; Tong Lin; Anne Bendel; Amar Gajjar; Brent A Orr
Journal:  Neuro Oncol       Date:  2015-02-16       Impact factor: 12.300

7.  Advancing biology-based therapeutic approaches for atypical teratoid rhabdoid tumors.

Authors:  Lindsey M Hoffman; Elizabeth Anne Richardson; Ben Ho; Ashley Margol; Alyssa Reddy; Lucie Lafay-Cousin; Susan Chi; Irene Slavc; Alexander Judkins; Martin Hasselblatt; Franck Bourdeaut; Michael C Frühwald; Rajeev Vibhakar; Eric Bouffet; Annie Huang
Journal:  Neuro Oncol       Date:  2020-07-07       Impact factor: 12.300

8.  Role of early and aggressive post-operative radiation therapy in improving outcome for pediatric central nervous system atypical teratoid/rhabdoid tumor.

Authors:  Wan-Chin Yang; Hsiu-Ju Yen; Muh-Lii Liang; Hsin-Hung Chen; Yi-Yen Lee; Tai-Tong Wong; Yu-Wen Hu; Yi-Wei Chen
Journal:  Childs Nerv Syst       Date:  2019-04-13       Impact factor: 1.475

Review 9.  Multimodal therapy in children and adolescents with newly diagnosed atypical teratoid rhabdoid tumor: individual pooled data analysis and review of the literature.

Authors:  D Schrey; F Carceller Lechón; G Malietzis; L Moreno; C Dufour; S Chi; L Lafay-Cousin; K von Hoff; T Athanasiou; L V Marshall; S Zacharoulis
Journal:  J Neurooncol       Date:  2015-11-25       Impact factor: 4.130

Review 10.  Case-based review: atypical teratoid/rhabdoid tumor.

Authors:  Cody L Nesvick; Amulya A Nageswara Rao; Aditya Raghunathan; Jaclyn A Biegel; David J Daniels
Journal:  Neurooncol Pract       Date:  2018-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.